Showing results (1-10 of 154) with videos related to
Sort By:
Pageof 16
Leukemia Research|October 15, 2015
Smoking as a contributing factor for development of polycythemia vera and related neoplasmsHans Carl HasselbalchUgeskrift for Laeger|June 27, 2002
[STI571 (Glivec)--a new drug for the treatment of chronic myeloid leukemia]Hans Carl HasselbalchLeukemia Research|July 18, 2008
Myelofibrosis with myeloid metaplasia: the advanced phase of an untreated disseminated hematological cancer. Time to change our therapeutic attitude with early upfront treatment?Hans Carl HasselbalchLeukemia Research|November 24, 2012
Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?Hans Carl HasselbalchLeukemia Research|August 24, 2014
The platelet-cancer loop in myeloproliferative cancer. Is thrombocythemia an enhancer of cancer invasiveness and metastasis in essential thrombocythemia, polycythemia vera and myelofibrosis?Hans Carl HasselbalchExpert Review of Hematology|November 15, 2011
A new era for IFN-α in the treatment of Philadelphia-negative chronic myeloproliferative neoplasmsHans Carl HasselbalchBlood Advances|February 26, 2026
Prime Time for The Use of Statins in MPNs: From Comorbidity Drugs to Disease-Modifying PartnersHans Carl HasselbalchAmerican Journal of Hematology|September 2, 2003
Acute leukemia and myelodysplasia in patients with a Philadelphia chromosome negative chronic myeloproliferative disorder treated with hydroxyurea alone or with hydroxyurea after busulphanIben Nielsen, Hans Carl HasselbalchHematology (Amsterdam, Netherlands)|February 23, 2016
Optimal therapy for polycythemia vera and essential thrombocythemia: Preferred use of interferon therapy based on phase 2 trialsRichard T Silver, Hans Carl HasselbalchPageof 16